Results 31 to 40 of about 22,412 (196)

Acute renal failure due to bilateral renal vein thromboses: A rare complication of heparin-induced thrombocytopenia

open access: yesAnnals of Cardiac Anaesthesia, 2019
Heparin-induced thrombocytopenia type II is a rare but devastating complication of heparin exposure. We review a case of a 66-year-old female who underwent aortic valve surgery requiring venoarterial extracorporeal membranous oxygenation (ECMO) support ...
Allan M Klompas   +3 more
doaj   +1 more source

Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. [PDF]

open access: greenJ Thromb Haemost
Myoung SS   +9 more
europepmc   +3 more sources

Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
We report a case of a 62‐year‐old man who developed cerebral venous sinus thrombosis with subarachnoid hemorrhage and concomitant thrombocytopenia, which occurred 13 days after ChAdOx1 nCov‐19 injection.
Alice Bérezné   +13 more
doaj   +1 more source

Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2018
Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 ...
Devon S. McKenzie MD   +3 more
doaj   +1 more source

Case Report: Heparin-induced thrombocytopenia during COVID-19 outbreak: the importance of scoring system in differentiating with sepsis-induced coagulopathy [version 1; peer review: 2 approved]

open access: yesF1000Research, 2021
Background: COVID-19 disease is accompanied by derangement of coagulation with a risk of fatal thromboembolic formation. COVID-19 patients are among those indicative for heparin treatment.
Louisa Fadjri Kusuma Wardhani   +3 more
doaj   +1 more source

Heparin-induced thrombocytopenia: an update

open access: yesThrombosis Journal, 2005
Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized.
Franchini Massimo
doaj   +1 more source

Heparin-induced thrombocytopenia following coronary artery bypass grafting: a diagnostic dilemma [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2015
The diagnosis of heparin-induced thrombocytopenia (HIT) is a challenge in post-cardiac surgery patients because of the high incidence of non-immune thrombocytopenia and heparin–platelet factor 4 antibodies in these groups.
Raju Khanal   +2 more
doaj   +1 more source

Delayed‐onset heparin‐induced thrombocytopenia complicated with saddle embolus

open access: yesClinical Case Reports, 2022
Delayed‐onset heparin‐induced thrombocytopenia is a rare complication of heparin in which thrombocytopenia and thrombosis occur several days after heparin cessation.
Faezeh Sadat Naji   +4 more
doaj   +1 more source

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata   +4 more
wiley   +1 more source

THE HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: Combination of ‘4Ts’ clinical scoring system and Particle gel immunoassay to determine the frequency of heparin-induced thrombocytopenia during heparin treatment in cardiac surgery patients. Study Design: Prospective observational study.
Shakila Khadim   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy